S. Chin

发表

Intramyocardial and intracoronary autologous bone marrow-derived mesenchymal stromal cell treatment in chronic severe dilated cardiomyopathy.

S. Cheong, S. Chin, Alfred C Poey, 2011, Cytotherapy.

Synergistic effects of intracoronary infusion of autologous bone marrow-derived mesenchymal stem cells and revascularization procedure on improvement of cardiac function in patients with severe ischemic cardiomyopathy.

O. Maskon, John E. Anderson, S. Cheong, 2021, Stem cell investigation.

High Dose of Intravenous Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells (CLV-100) Infusion Displays Better Immunomodulatory Effect among Healthy Volunteers: A Phase 1 Clinical Study

K. Then, S. Cheong, S. Chin, 2020, Stem cells international.

Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy.

S. Cheong, S. Chin, Alfred C Poey, 2010, Cytotherapy.

The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy.

H. Tan, Mohd Izhar Ariff, A. Muda, 2021, Cytotherapy.

Dynamic tracking of human umbilical cord mesenchymal stem cells (hUC-MSCs) following intravenous administration in mice model

K. Then, A. Salleh, Marini Marzuki, 2024, Regenerative therapy.

Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy.

S. Cheong, S. Chin, Alfred C Poey, 2010, Cytotherapy.

Secretome profile of TNF-α-induced human umbilical cord mesenchymal stem cells unveils biological processes relevant to skin wound healing.

S. Chin, Lihui Tai, N. Saffery, 2023, Regenerative medicine.